The Evolving Role of Inotropes in Pediatric Septic Shock: Shifting Paradigms from Fluid First to Vasoactive Early

jpedsurg.org

Septic shock in the pediatric population is one of the alarming conditions. Septic shock results from the Systemic inflammatory response to infection, which leads to cellular circulatory and metabolic abnormalities, ultimately resulting in high morbidity and mortality rates. An estimated 25 million cases of sepsis have been reported in pediatric and neonatal age groups, resulting in more than 3 million deaths across the globe. Increased septic load in the pediatric population has been reported to have a mortality rate of 25% across 26 countries.

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Jul 2025 · 1 min read

In brief

This article examines the paradigm shift in managing pediatric septic shock, moving from traditional fluid-first approaches to earlier initiation of vasoactive medications. With sepsis affecting 25 million children globally and mortality rates reaching 25%, optimizing hemodynamic support strategies is critical for improving outcomes in this high-risk population.

Septic shock causes systemic inflammation leading to circulatory and metabolic dysfunction with high pediatric mortality rates.
Approximately 25 million pediatric/neonatal sepsis cases occur globally, resulting in over 3 million deaths annually.
Pediatric septic shock mortality reaches 25% across multiple countries, highlighting the critical need for early intervention.
Treatment paradigms are shifting from fluid-first approaches to earlier vasoactive agent administration in pediatric septic shock.
Early recognition and prompt vasoactive support may improve outcomes in pediatric patients with septic shock.

Written by the GCMD Library team from the article.

Read it at the source ↗